Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -69,234 | -311,351 | -224,370 | -142,195 | -65,581 |
| Depreciation Amortization | -708 | -566 | -553 | -514 | -477 |
| Accounts receivable | N/A | N/A | N/A | -40,000 | N/A |
| Accounts payable and accrued liabilities | 8,824 | -1,974 | -483 | -216 | 3,917 |
| Other Working Capital | -34,905 | 15,266 | 9,473 | -25,974 | -27,325 |
| Other Operating Activity | 7,183 | 65,734 | 49,789 | 69,865 | 10,316 |
| Operating Cash Flow | $-88,840 | $-232,891 | $-166,144 | $-139,034 | $-79,150 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -434 | -1,449 | -1,343 | -1,162 | -467 |
| Purchase Of Investment | -276,266 | -1,007,628 | -509,465 | -141,907 | -83,656 |
| Sale Of Investment | 133,860 | 488,016 | 384,145 | 251,705 | 132,738 |
| Investing Cash Flow | $-142,840 | $-521,061 | $-126,663 | $108,636 | $48,615 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -425 | -1,494 | -1,078 | -659 | -277 |
| Common Stock Issued | 19,194 | 992,207 | 286,572 | 246,643 | 535 |
| Financing Cash Flow | $18,769 | $990,713 | $285,494 | $245,984 | $258 |
| Beginning Cash Position | 362,811 | 126,050 | 126,050 | 126,050 | 126,050 |
| End Cash Position | 149,900 | 362,811 | 118,737 | 341,636 | 95,773 |
| Net Cash Flow | $-212,911 | $236,761 | $-7,313 | $215,586 | $-30,277 |
| Free Cash Flow | |||||
| Operating Cash Flow | -88,840 | -232,891 | -166,144 | -139,034 | -79,150 |
| Capital Expenditure | -434 | -1,449 | -1,343 | -1,162 | -467 |
| Free Cash Flow | -89,274 | -234,340 | -167,487 | -140,196 | -79,617 |